Related Experiment Video
Updated: May 22, 2025
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
553
Tumor-Infiltrating Lymphocyte Therapy: A New Frontier
1Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Transplantation and Cellular Therapy
|March 15, 2025
Summary
Tumor-infiltrating lymphocyte (TIL) therapy shows promise beyond melanoma, with ongoing research focusing on enhanced TIL design and manufacturing for broader solid tumor applications.
Area of Science:
- Immunology
- Oncology
- Cellular Therapy
Background:
- Tumor-infiltrating lymphocyte (TIL) therapy has achieved FDA approval for melanoma treatment.
- This success has spurred significant advancements in TIL cellular immunotherapy.
- The field is rapidly expanding with new research into TIL enhancements and broader applications.
Purpose of the Study:
- To review the latest advancements in TIL therapy.
- To explore future potential indications for TIL therapy in solid tumors.
- To discuss innovations in designing next-generation TILs.
Main Methods:
- Review of recent scientific literature and clinical trial data.
- Analysis of emerging trends in TIL therapy development.
- Exploration of novel strategies for TIL enhancement.
Main Results:
- TIL therapy is being investigated for various solid tumors beyond melanoma.
- Innovations focus on improving TIL specificity, persistence, safety, and function.
- Refined manufacturing strategies aim to enrich for more potent TIL populations.
Conclusions:
- TIL therapy holds significant potential for treating a wider range of solid cancers.
- Future directions involve developing more advanced and effective TIL designs.
- Continued research and clinical trials are crucial for expanding TIL therapy's impact.
Related Concept Videos
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K